|

ABBV-324 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • AbbVie1

Indications

  • Liver Disease1
  • Squamous-Cell Non-Small Cell Lung Cancer1
  • Hepatocellular Cancer1
  • Liver Cancer1
  • Lung Cancer1

Duarte, California1 trial

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

City of Hope National Medical Center /ID# 270526

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.